Sio Capital Management
Latest statistics and disclosures from Sio Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ICLR, MMS, CI, LH, SNY, and represent 39.72% of Sio Capital Management's stock portfolio.
- Added to shares of these 10 stocks: ICLR (+$41M), CI (+$20M), SNY (+$19M), MMS (+$17M), DRUG (+$16M), Anteris Technologies Global (+$13M), VTRS (+$9.1M), OGN (+$9.0M), ANIP (+$8.8M), EMBC (+$8.8M).
- Started 22 new stock positions in ANIP, ALEC, Alpha Cognition, Anteris Technologies Global, TELA, Septerna, PRQR, ICLR, OVID, DRUG. CCCC, SNY, IRWD, VTRS, TARA, NMRA, EMBC, QTTB, MESO, SVRA, VIR, OGN.
- Reduced shares in these 10 stocks: , TEVA (-$24M), LH (-$14M), KVUE (-$11M), BDSX (-$7.7M), IRON (-$7.3M), RLAY (-$6.7M), CMPS (-$5.8M), TYRA, ERAS.
- Sold out of its positions in BDSX, Caremax, CMPS, ISRG, KVUE, RAPT, RLAY, TEVA, VSTM, XFOR.
- Sio Capital Management was a net buyer of stock by $120M.
- Sio Capital Management has $355M in assets under management (AUM), dropping by 40.94%.
- Central Index Key (CIK): 0001482416
Tip: Access up to 7 years of quarterly data
Positions held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 51 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Icon SHS (ICLR) | 11.5 | $41M | NEW | 196k | 209.71 |
|
| Maximus (MMS) | 8.0 | $29M | +145% | 381k | 74.65 |
|
| Cigna Corp (CI) | 7.6 | $27M | +269% | 98k | 276.14 |
|
| Labcorp Holdings Com Shs (LH) | 7.3 | $26M | -34% | 113k | 229.32 |
|
| Sanofi Sponsored Adr (SNY) | 5.3 | $19M | NEW | 387k | 48.23 |
|
| Zimmer Holdings (ZBH) | 5.2 | $19M | +37% | 175k | 105.63 |
|
| Bright Minds Biosciences Com New (DRUG) | 4.6 | $16M | NEW | 452k | 36.02 |
|
| Anteris Technologies Global | 3.7 | $13M | NEW | 2.4M | 5.58 |
|
| Annexon (ANNX) | 3.4 | $12M | +65% | 2.4M | 5.13 |
|
| Teleflex Incorporated (TFX) | 3.3 | $12M | +70% | 67k | 177.98 |
|
| Viatris (VTRS) | 2.6 | $9.1M | NEW | 730k | 12.45 |
|
| Organon & Co Common Stock (OGN) | 2.5 | $9.0M | NEW | 606k | 14.92 |
|
| Ventyx Biosciences (VTYX) | 2.5 | $8.9M | +105% | 4.0M | 2.19 |
|
| Biosante Pharmaceuticals (ANIP) | 2.5 | $8.8M | NEW | 160k | 55.28 |
|
| Embecta Corp Common Stock (EMBC) | 2.5 | $8.8M | NEW | 426k | 20.65 |
|
| Vir Biotechnology (VIR) | 2.2 | $7.7M | NEW | 1.1M | 7.34 |
|
| Vaxart Com New (VXRT) | 2.1 | $7.6M | -15% | 12M | 0.66 |
|
| Protara Therapeutics Com Stk (TARA) | 2.1 | $7.6M | NEW | 1.4M | 5.28 |
|
| Cargo Therapeutics (CRGX) | 1.9 | $6.8M | +172% | 473k | 14.42 |
|
| Neumora Therapeutics (NMRA) | 1.9 | $6.7M | NEW | 636k | 10.60 |
|
| Septerna | 1.8 | $6.2M | NEW | 272k | 22.90 |
|
| Proqr Therapeutics N V Shs Euro (PRQR) | 1.5 | $5.4M | NEW | 2.1M | 2.65 |
|
| Pmv Pharmaceuticals (PMVP) | 1.5 | $5.4M | +11% | 3.6M | 1.51 |
|
| Disc Medicine (IRON) | 1.3 | $4.7M | -60% | 74k | 63.40 |
|
| Astria Therapeutics (ATXS) | 1.3 | $4.5M | 505k | 8.94 |
|
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 1.1 | $4.0M | NEW | 908k | 4.43 |
|
| CryoLife (AORT) | 1.0 | $3.5M | 121k | 28.59 |
|
|
| Erasca (ERAS) | 1.0 | $3.4M | -38% | 1.4M | 2.51 |
|
| Tyra Biosciences (TYRA) | 0.9 | $3.3M | -39% | 241k | 13.90 |
|
| Ideaya Biosciences (IDYA) | 0.9 | $3.2M | 123k | 25.70 |
|
|
| Alpha Cognition Com New | 0.7 | $2.6M | NEW | 435k | 5.89 |
|
| Q32 Bio (QTTB) | 0.7 | $2.4M | NEW | 697k | 3.44 |
|
| Tela Bio (TELA) | 0.5 | $1.9M | NEW | 630k | 3.02 |
|
| Nuvation Bio Com Cl A (NUVB) | 0.5 | $1.8M | 668k | 2.66 |
|
|
| Context Therapeutics (CNTX) | 0.4 | $1.4M | 1.3M | 1.05 |
|
|
| Alector (ALEC) | 0.3 | $1.2M | NEW | 616k | 1.89 |
|
| Enanta Pharmaceuticals (ENTA) | 0.3 | $1.0M | 177k | 5.75 |
|
|
| Ovid Therapeutics (OVID) | 0.3 | $934k | NEW | 1.0M | 0.93 |
|
| Aprea Therapeutics Com New (APRE) | 0.3 | $910k | 277k | 3.29 |
|
|
| Foghorn Therapeutics (FHTX) | 0.2 | $574k | 122k | 4.72 |
|
|
| C4 Therapeutics Com Stk (CCCC) | 0.2 | $558k | NEW | 155k | 3.60 |
|
| Avalo Therapeutics Com New (AVTX) | 0.1 | $531k | 72k | 7.43 |
|
|
| Boundless Bio (BOLD) | 0.1 | $470k | 162k | 2.90 |
|
|
| Nyxoah S A SHS (NYXH) | 0.1 | $407k | 51k | 8.00 |
|
|
| Modular Med Com New (MODD) | 0.1 | $345k | +108% | 252k | 1.37 |
|
| Mesoblast Spons Adr (MESO) | 0.1 | $230k | NEW | 12k | 19.80 |
|
| Nextcure (NXTC) | 0.0 | $100k | 130k | 0.77 |
|
|
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $92k | 50k | 1.83 |
|
|
| Terns Pharmaceuticals (TERN) | 0.0 | $55k | 10k | 5.54 |
|
|
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $15k | 400k | 0.04 |
|
|
| Savara (SVRA) | 0.0 | $12k | NEW | 3.7k | 3.07 |
|
Past Filings by Sio Capital Management
SEC 13F filings are viewable for Sio Capital Management going back to 2010
- Sio Capital Management 2024 Q4 filed Feb. 14, 2025
- Sio Capital Management 2024 Q3 filed Nov. 14, 2024
- Sio Capital Management 2024 Q2 filed Aug. 14, 2024
- Sio Capital Management 2024 Q1 filed May 15, 2024
- Sio Capital Management 2023 Q3 filed Nov. 14, 2023
- Sio Capital Management 2023 Q2 filed Aug. 14, 2023
- Sio Capital Management 2023 Q1 filed May 12, 2023
- Sio Capital Management 2022 Q4 filed Feb. 13, 2023
- Sio Capital Management 2022 Q3 filed Nov. 14, 2022
- Sio Capital Management 2022 Q2 filed Aug. 15, 2022
- Sio Capital Management 2022 Q1 filed May 16, 2022
- Sio Capital Management 2021 Q4 filed Feb. 14, 2022
- Sio Capital Management 2021 Q3 filed Nov. 15, 2021
- Sio Capital Management 2021 Q2 filed Aug. 16, 2021
- Sio Capital Management 2021 Q1 filed May 14, 2021
- Sio Capital Management 2020 Q4 filed Feb. 16, 2021